ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2015 American Transplant Congress

    Customized Reminders and Provider Notification to Improve Adherence to Immunosuppression

    P. Reese, R. Bloom, J. Trofe-Clark, A. Mussell, D. Leidy, S. Levsky, J. Zhu, Y. Lin, A. Troxel, H. Feldman, K. Volpp.

    UPenn, Philadelphia, PA.

    Background: Non-adherence to transplant immunosuppression is associated with an elevated risk of allograft loss. Novel, wireless-enabled pill bottles have created the opportunity to monitor patient…
  • 2015 American Transplant Congress

    Microvascular (MIA) and Interstitial (i) Inflammation Influence Late Death-Censored Graft Failure (DCGF) After Kidney Transplantation

    R. Gaston,1 A. Fieberg,2 R. Leduc,2 J. Connett,2 F. Cosio,3 S. Gourishankar,4 J. Grande,3 L. Hunsicker,5 B. Kasiske,6 J. Cecka,7 A. Matas,2 D. Rush.8

    1UAB, Birmingham; 2U Minnesota, Minneapolis; 3Mayo Clinic, Rochester; 4U Alberta, Edmonton, Canada; 5U Iowa, Iowa City; 6Hennepin County Med Ctr, Minneapolis; 7UCLA Immunogenetics, Los Angeles; 8U Manitoba, Winnipeg, Canada.

    We and others have shown late DCGF is due to ongoing, most often immune, injury. Though there is general agreement that antibody-mediated injury is a…
  • 2015 American Transplant Congress

    Elective Allograft Nephrectomy After Transplant Failure

    J. Augustine, K. Woodside, K. Noon, D. Hricik, E. Sanchez, J. Schulak.

    University Hospitals, Transplant Institute, Cleveland, OH.

    Background/Methods: Because of high rates of allograft intolerance and alloantibody sensitization after kidney transplant failure, we undertook a pilot study of elective allograft nephrectomy (ENx)…
  • 2015 American Transplant Congress

    Husband to Wife Renal Transplants Are Associated With a Higher Risk of Early Antibody Mediated Rejection and Transplant Glomerulopathy

    H. Sawhney, M. Willicombe, P. Brookes, E. Santos, D. Taube.

    Renal and Transplant Centre, Hammersmith Hospital, Imperial Healthcare NHS Trust, London, England, United Kingdom.

    Patients with a low level preformed donor specific antibodies [DSA] with a negative FCXM/CDC cross match are at high risk of antibody mediated rejection [AMR]…
  • 2015 American Transplant Congress

    Kidney Transplantation in the Septuagenarian

    H. Saucedo Crespo, B. Taner, M. Mai, H. Wadei, P. Perry, M. Prendergast, J. Nguyen, K. Oshel, J. Bruns, D. Lee, T. Gonwa.

    Department of Transplantation, Mayo Clinic, Jacksonville, FL.

    The elderly ESRD population in the US continues to grow. National data demonstrates that both patient (PS) and graft survival (GS) at 1 and 5…
  • 2015 American Transplant Congress

    Differences in Reactivity of HLA-Specific Antibodies May Be Explained By Differences in Their Affinities for Selected Epitopes on HLA Proteins

    S. Daga,1,2 D. Lowe,6 R. Buchli,5 J. Collard,5 A. Mulder,8 C. McMurtrey,4,5 H. Moyse,7 N. Evans,7 N. Krishnan,2 W. Hildebrand,4,5 F. Claas,8 D. Briggs,3 D. Zehnder,1,2 D. Mitchell,1 R. Higgins.1,2

    1Clinical Sciences Research Laboratories, University of Warwick, Coventry, United Kingdom; 2Renal Unit, University Hospital, Coventry and Warwickshire NHS Trust, Coventry, United Kingdom; 3Department of Histocompatibility and Immunogenetics, NHS Blood and Transplant, Birmingham, United Kingdom; 4University of Oklahoma Health Science Center, Oklahoma City; 5Pure Protein LLC, Oklahoma City; 6Department of Histocompatibility and Immunogenetics, Royal Liverpool University Hospital, Liverpool, United Kingdom; 7School of Engineering, University of Warwick, Coventry, United Kingdom; 8Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands.

    Affinity of IgG immunoglobulins for antigen varies and matures within the evolution of immune responses. Affinity is likely to be different for different epitope-antibody interactions…
  • 2015 American Transplant Congress

    Campath Induction With Triple Maintenance Therapy in African American Kidney Transplant Recipients: Less Infections But Worse Graft Survival

    M. Gillespie, F. Rasetto, B. Masters, T. Sparkes, B. Ravichandran, M. Moss, A. Haririan.

    University of Maryland Medical Center, Baltimore, MD.

    Introduction:African American (AA) kidney transplant recipients (KTR) are at a higher risk for worse clinical outcomes vs non-AA. Strategies to improve outcomes in AA KTR…
  • 2015 American Transplant Congress

    High Kidney Donor Profile Index (KDPI) Correlates With Calculated Pulsatile Perfusion (PP) Resistance Index (RI) and Delayed Graft Function (DGF)

    R. Pelletier, M. Henry.

    Surgery/Transplant, The Ohio State University Medical Center, Columbus, OH.

    Background: Deceased donor (DD) kidney quality is now being determined by calculating the Kidney Donor Profile Index (KDPI). Calculated kidney vascular resistance index (RI) during…
  • 2015 American Transplant Congress

    Socioeconomic Factors and Early Hospital Readmission After Kidney Transplant at a Single Center

    J. Lin, E. King, R. Craig-Shapiro, C. Wickliffe, A. Massie, D. Segev.

    Department of Surgery, Johns Hopkins School of Medicine, Baltimore.

    Early hospital readmission (EHR) is a key negative outcome in kidney transplantation (KT). Socioeconomic (SE) factors are associated with EHR in other contexts, but have…
  • 2015 American Transplant Congress

    Efficacy of Rituximab Sparing Protocol for ABO Incompatible Renal Transplant in Patients With Low Titers

    S. Narumi,1 Y. Watarai,1 N. Goto,1 T. Hiramitsu,1 T. Yamamoto,1 M. Tsujita,1 M. Okada,1 K. Futamura,1 A. Takeda,2 T. Kobayashi.3

    1Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan; 2Nephrology, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan; 3Applied Immunology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

    [Introduction]Acute antibody mediated rejection (AMR) has been a major problem in ABO-incompatible kidney transplantation (ABOi-KTx), and currently mycophenolate mofetil and rituximab have been used to…
  • « Previous Page
  • 1
  • …
  • 520
  • 521
  • 522
  • 523
  • 524
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences